Pseudofolliculitis Barbae Clinical Trial
Official title:
The Impact of the 556 Razor Technology and of a Regimen of the 556 Razor Technology With Pre-Shave Gel and Brush on Shaving Satisfaction in Males With Skin Irritation From Shaving
The purpose of this research study is to evaluate the improvement in overall shave satisfaction, the appearance of skin irritation from shaving, and the razor related inflammation of the hair follicles when using a new razor technology in a regular shaving regimen as well as a new razor technology in a shaving regimen that includes a pre-shave gel, cleansing brush and shaving gel.
A secondary objective is to show improvement in the satisfaction of the shaving experience, symptoms such as bumps and irritation, and quality of life (QOL), when adding the 556 Razor, or the 556 Razor with a regimen of pre-shave gel, cleansing brush, and shave gel to the shaving regimen of males with shaving skin irritation. Shaving irritation severity will be correlated to shave satisfaction. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04403282 -
Topical Eflornithine for Pseudofolliculitis Barbae: Randomized Controlled Trial
|
Phase 4 | |
| Completed |
NCT04993066 -
Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro Plus
|
N/A | |
| Completed |
NCT03043534 -
Pre-Shave Gel and Brush in Pseudofolliculitis Barbae
|
N/A | |
| Completed |
NCT00176995 -
Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae
|
Phase 2 | |
| Completed |
NCT00402129 -
Low Fluence 1064nm Laser Hair Reduction for Pseudofolliculitis Barbae in Skin Types IV, V, VI
|
N/A | |
| Withdrawn |
NCT04220502 -
Magic Shave Powder Gold's Affects on the Occurrence of Pseudofolliculitis Barbae
|
Early Phase 1 |